12 results
8-K
EX-99.2
GOSS
Gossamer Bio Inc
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
-to-severe eosinophilic asthma A small minority are treated with approved biologic agents An additional ~1.5 million patients without elevated eosinophils
10-K
8jn4r6
22 Mar 19
Annual report
4:45pm
424B4
zrq4e9vp64nq4cwt9t
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
6mp79o3jk wwr91uhg13
23 Jan 19
IPO registration (amended)
4:39pm
S-1
tqy2vnt 2pj
21 Dec 18
IPO registration
4:39pm
DRS/A
pmnr0tnh 39k6x97o
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
lqr4ikd10lc kh7
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next